Follicle-stimulating hormone (FSH) is a key hormone in the regulation of fo
llicular development. Although the existence of FSH heterogeneity is well e
stablished, the physiological significance of this pleomorphism remains unk
nown. Observed changes in circulating FSH heterogeneity during critical rep
roductive events such as puberty and reproductive cyclicity suggest that di
fferent combinations of FSH isoforms reach the target sites during differen
t physiological states to influence a variety of biological end points such
as cellular growth, development, steroidogenesis and protein synthesis. Co
nsidering that these FSH isoforms have different physicochemical properties
and potential to bind not only their cognate receptors but also structural
ly related, non-FSH receptors with various affinities, the regulatory impli
cations of FSH heterogeneity in modulating the various FSH-induced function
s are enormous. However, assigning functional significance to FSH heterogen
eity has been hampered because of (1) difficulties associated with procurem
ent of highly purified, naturally occurring, circulating FSH isoforms; (2)
absence of reference standards that contain the entire repertoire of FSH is
oforms present in biological fluids; and (3) specificity issues inherent to
the detection systems used. if particular FSH isoforms do possess selectiv
e biological functions, specific combinations of FSH isoforms could be gene
rated to regulate fertility in farm animals and humans.